禁煙とニコチン中毒解消の世界市場分析:製品別(ニコチン置換療法、吸入器、歯茎、パッチ、麻薬、スプレー、舌下錠、バレニクリン、ブプロピオン、薬物療法、電子タバコ)、セグメント予測

◆英語タイトル:Smoking Cessation And Nicotine De-addiction Market Analysis By Product (Nicotine Replacement Therapy, Inhalers, Gums, Patches, Lozenges, Sprays, Sublingual Tablets, Varenicline, Bupropione, Drug therapy, E-cigarettes) And Segment Forecasts To 2024
◆商品コード:GVIEW707789
◆発行会社(調査会社):Grand View Research
◆発行日:2016年6月21日
◆ページ数:84
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆調査対象地域:グローバル
◆産業分野:医療
◆販売価格オプション(消費税別)
Single UserUSD4,700 ⇒換算¥531,100見積依頼/購入/質問フォーム
Multi UserUSD8,000 ⇒換算¥904,000見積依頼/購入/質問フォーム
Global/corporate LicenseUSD10,500 ⇒換算¥1,186,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご確認ください。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(支払期限と方法は調整可能、振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGrand View Research社の日本における正規販売代理店です。Grand View Research社の概要及び新刊レポートはこちらでご確認いただけます。
本調査レポートでは、禁煙とニコチン中毒解消の世界市場について調査・分析し、禁煙とニコチン中毒解消の世界市場動向、禁煙とニコチン中毒解消の世界市場規模、市場予測、セグメント別禁煙とニコチン中毒解消市場分析、主要地域別市場規模、競争状況、関連企業情報などを含め、以下の構成でお届け致します。
【レポートの概要】

The global smoking cessation and nicotine de-addiction market is expected to reach over USD 21.8 billion by 2024 according to a new report by Grand View Research, Inc.
The base of population addicted to smoking is rapidly increasing across the globe. This population subset majorly includes teenagers and the working population. Smoking-related mortality is very high. The increasing desire to quit smoking and the numerous health complications associated with smoking serve as strong incentives for companies to introduce novel smoking cessation products, such as Revolymer, which has introduced the next generation nicotine gums to help smokers quit smoking. The launch of these improved and innovative nicotine replacement therapy products is to serve as a high impact rendering driver for the growth of the smoking cessation and nicotine de-addiction market.

The growing incidence of target diseases such as chronic obstructive pulmonary disease (COPD), asthma, cardiac diseases, and lung cancer, and the increasing awareness pertaining to the hazardous side-effects of smoking are the factors expected to promote market expansion. Educational institutions remain active in organizing various campaigns and programs to spread information about the harmful effects and consequences of smoking so as to increase young population awareness.

Further key findings from the study suggest:

Nicotine Replacement Therapy (NRT) dominated the smoking cessation and de-nicotine addiction product market in 2015. Majorly used NRT products include nicotine chewing gums and the transdermal patches. Increased availability and the introduction of the ingestible nicotine products with different flavors are the factors responsible for its large market share.

The e-cigarette segment is anticipated to grow at a CAGR of19.0% over the forecast period. The major factors responsible for the growth of the E-cigarette market include the introduction of second and third generation e-cigarettes, the availability of various flavored products, the presence of numerous vendors operating and selling e-cigarettes under different brand names.

North America held a large market share of over 35.0% in 2015 owing to the high awareness levels of nicotine de-addiction products with around 90% of the U.S. population were identified as aware of e-cigarettes in 2015

Asia Pacific is the fastest growing market. The registration of nicotine de-addiction products and e-cigarettes as well as the strengthening of the company distribution channels in countries, such as China, India, and Australia are expected to support the growth over the forecast period

Some key players of this market are Pfizer, Inc., Cipla Ltd., Novartis International AG, GlaxoSmithKline plc, Takeda pharmaceutical Company Ltd., McNeil AB, Revolymer plc, Imperial Tobacco Ltd., and VMR products, LLC

The market players are making slow but steady progress in the e-cigarette market by focusing on the development, commercialization, and distribution of the FDA approved nicotine products. For instance, in 2014, Victory Electronic Cigarettes Corporation acquired Ten Motives Ltd. with an aim to expand their distribution channels and attain wider market coverage.

【レポートの目次】

Table of Content

Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
1.3. List of Data Sources
Chapter 2. Executive Summary
2.1. Smoking Cessation and Nicotine De-addiction Market- Industry Snapshot and Key Buying Criteria, 2015
Chapter 3. Smoking Cessation and Nicotine De-addiction Industry Outlook
3.1. Smoking Cessation and Nicotine De-addiction Market Segmentation
3.2. Smoking Cessation and Nicotine De-addiction Market Size and Growth Prospects
3.3. Smoking Cessation and Nicotine De-addiction Market Dynamics
3.3.1. Market Driver Analysis
3.3.1.1. Increasing demand for Nicotine De-addiction products
3.3.1.2. General awareness regarding the associated side-effects of smoking
3.3.1.3. Launch of new Nicotine De-addiction products
3.3.2. Market Restraint Analysis
3.4. Industry Analysis – Porter’s
3.5. Smoking Cessation and Nicotine De-addiction Market PESTEL Analysis, 2015
Chapter 4. Smoking Cessation and Nicotine De-addiction Product Outlook
4.1. Smoking Cessation and Nicotine De-addiction Market Share By Product, 2015& 2024
4.2. Nicotine Replacement Market Estimates and Forecasts, 2013 – 2024 (USD Million)
4.2.1. Nicotine Sprays Market Estimates and Forecasts, 2013 – 2024 (USD Million)
4.2.2. Nicotine Inhalers Market Estimates and Forecasts, 2013 – 2024 (USD Million)
4.2.3. Nicotine Gums Market Estimates and Forecasts, 2013 – 2024 (USD Million)
4.2.4. Nicotine Transdermal Patches Market Estimates and Forecasts, 2013 – 2024 (USD Million)
4.2.5. Nicotine Sublingual Tablets Market Estimates and Forecasts, 2013 – 2024 (USD Million)
4.2.6. Nicotine Lozenges Market Estimates and Forecasts, 2013 – 2024 (USD Million)
4.3. Drug Therapy Market Estimates and Forecasts, 2013 – 2024 (USD Million)
4.3.1. Varenicline Oral Market Estimates and Forecasts, 2013 – 2024 (USD Million)
4.3.2. Zyban Oral Market Estimates and Forecasts, 2013 – 2024 (USD Million)
4.3.3. Nicorette Buccal Market Estimates and Forecasts, 2013 – 2024 (USD Million)
4.4. E-cigarettes/ E-liquid Market Estimates and Forecasts, 2013 – 2024 (USD Million)
Chapter 5. Smoking Cessation and Nicotine De-addiction Regional Outlook
5.1. Smoking Cessation and Nicotine De-addiction Market Share By Region, 2015 -2024
5.2. North America
5.2.1. North America Market Estimates and Forecasts, by Product, 2013 – 2024 (USD Million)
5.2.1.1. U.S. Market Estimates and Forecasts
5.2.1.2. Canada Market Estimates and Forecasts
5.3. Europe
5.3.1. Europe Market Estimates and Forecasts, by Product, 2013 – 2024 (USD Million)
5.3.1.1. Germany Market Estimates and Forecasts
5.3.1.2. UK Market Estimates and Forecasts
5.4. Asia Pacific
5.4.1. Asia Pacific Market Estimates and Forecasts, by Product, 2013 – 2024 (USD Million)
5.4.1.1. Japan Market Estimates and Forecasts
5.4.1.2. China Market Estimates and Forecasts
5.5. Latin America
5.5.1. Latin America Market Estimates and Forecasts, by Product, 2013 – 2024 (USD Million)
5.5.1.1. Brazil Market Estimates and Forecasts
5.6. MEA
5.6.1. MEA Market Estimates and Forecasts, by Product, 2013 – 2024 (USD Million)
5.6.1.1. South Africa Market Estimates and Forecasts
Chapter 6. Competitive Landscape
6.1. Pfizer, Inc.
6.1.1. Company Overview
6.1.2. Financial Performance
6.1.3. Product Benchmarking
6.1.4. Strategic Initiatives
6.2. GSK plc
6.2.1. Company Overview
6.2.2. Financial Performance
6.2.3. Product Benchmarking
6.2.4. Strategic Initiatives
6.3. Cipla Ltd.
6.3.1. Company Overview
6.3.2. Financial Performance
6.3.3. Product Benchmarking
6.3.4. Strategic Initiatives
6.4. Novartis International AG
6.4.1. Company Overview
6.4.2. Financial Performance
6.4.3. Product Benchmarking
6.4.4. Strategic Initiatives
6.5. McNeil AB
6.5.1. Company Overview
6.5.2. Financial Performance
6.5.3. Product Benchmarking
6.5.4. Strategic Initiatives
6.6. Revolymer plc
6.6.1. Company Overview
6.6.2. Financial Performance
6.6.3. Product Benchmarking
6.6.4. Strategic Initiatives
6.7. Takeda Pharmaceutical Company Ltd.
6.7.1. Company Overview
6.7.2. Financial Performance
6.7.3. Product Benchmarking
6.7.4. Strategic Initiatives
6.8. Imperial Tobacco Ltd.
6.8.1. Company Overview
6.8.2. Financial Performance
6.8.3. Product Benchmarking
6.8.4. Strategic Initiatives
6.9. VMR products, LLC
6.9.1. Company Overview
6.9.2. Financial Performance
6.9.3. Product Benchmarking
6.9.4. Strategic Initiatives

List of Figures

FIG. 1 Smoking Cessation And Nicotine De-addiction MarketSegmentation
FIG. 2 Smoking Cessation and Nicotine De-addiction Market Revenue, 2013 - 2024 (USD Million)
FIG. 3 Smoking Cessation and Nicotine De-addiction Market Dynamics
FIG. 4 Key Opportunities Prioritized
FIG. 5 Smoking Cessation and Nicotine De-addiction arket- Porter’s Analysis
FIG. 6 Smoking Cessation and Nicotine De-addiction Market- PESTEL Analysis
FIG. 7 Smoking Cessation and Nicotine De-addiction Market Share by Product, 2013& 2024
FIG. 8 Smoking Cessation and Nicotine De-addiction Market Share by Country, 2013& 2024
FIG. 9 North America Smoking Cessation and Nicotine De-addiction Market, by Product, 2013 - 2024 (USD Million)
FIG. 10 U.S. Smoking Cessation and Nicotine De-addiction Market, by Product, 2013 - 2024 (USD Million)
FIG. 11 Canada Smoking Cessation and Nicotine De-addiction Market, by Product, 2013 - 2024 (USD Million)
FIG. 12 Europe Smoking Cessation and Nicotine De-addiction Market, by Product, 2013 - 2024 (USD Million)
FIG. 13 UK Smoking Cessation and Nicotine De-addiction Market, by Product, 2013 - 2024 (USD Million)
FIG. 14 Germany Smoking Cessation and Nicotine De-addiction Market, by Product, 2013 - 2024 (USD Million)
FIG. 15 Asia Pacific Smoking Cessation and Nicotine De-addiction Market, by Product, 2013 - 2024 (USD Million)
FIG. 16 China Smoking Cessation and Nicotine De-addiction Market, by Product, 2013 - 2024 (USD Million)
FIG. 17 Japan Smoking Cessation and Nicotine De-addiction Market, by Product, 2013 - 2024 (USD Million)
FIG. 18 Latin America Smoking Cessation and Nicotine De-addiction Market, by Product, 2013 - 2024 (USD Million)
FIG. 19 Brazil Smoking Cessation and Nicotine De-addictionMarket, by Product, 2013 - 2024 (USD Million)
FIG. 20 MEA Smoking Cessation and Nicotine De-addiction Market, by Product, 2013 - 2024 (USD Million)
FIG. 21 South Africa Smoking Cessation and Nicotine De-addiction Market, by Product, 2013 - 2024 (USD Million)



★調査レポート[禁煙とニコチン中毒解消の世界市場分析:製品別(ニコチン置換療法、吸入器、歯茎、パッチ、麻薬、スプレー、舌下錠、バレニクリン、ブプロピオン、薬物療法、電子タバコ)、セグメント予測] (コード:GVIEW707789)販売に関する免責事項を必ずご確認ください。
★調査レポート[禁煙とニコチン中毒解消の世界市場分析:製品別(ニコチン置換療法、吸入器、歯茎、パッチ、麻薬、スプレー、舌下錠、バレニクリン、ブプロピオン、薬物療法、電子タバコ)、セグメント予測]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆